10x Insights
Loading account…
Companies / Healthcare / SHOULDER INNOVATIONS, INC.
SI

SHOULDER INNOVATIONS, INC.

HealthcareSurgical & Medical Instruments
Ticker SIGRAND RAPIDS, MIFiscal year ends DecemberBook value per share $6.01Diluted shares 20.7M

Shoulder Innovations, Inc. (NYSE: SHLD) is a commercial-stage medical technology company exclusively focused on transforming shoulder surgical care through advanced implant systems and enabling technologies. The company develops and commercializes a comprehensive ecosystem designed to address clinical and operational… From the company’s description.

Fiscal year 2025 · ends 12-31The amber dot is the latest twelve months, to 2026-06-30
Sales & profitability
$47.32M
Last 12 mo $60.06M
-55.58%
Last 12 mo -58.53%
$-40.36M
Last 12 mo $-35.03M
-28.67%
Last 12 mo -28.18%
Cash & financing
$-28.61M
Last 12 mo $-37.09M
$-36.02M
Last 12 mo $-47.08M
0.11
Last 12 mo 0.12
8.7M
Last 12 mo 20.7M

Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.

What SHOULDER INNOVATIONS, INC. does

In the company’s own words

Shoulder Innovations, Inc. (NYSE: SHLD) is a commercial-stage medical technology company exclusively focused on transforming shoulder surgical care through advanced implant systems and enabling technologies. The company develops and commercializes a comprehensive ecosystem designed to address clinical and operational challenges in shoulder arthroplasty procedures, which represent the company's primary addressable market.

The company's core product portfolio includes advanced implant systems for both anatomic total shoulder arthroplasty (aTSA) and reverse total shoulder arthroplasty (rTSA) procedures, featuring proprietary InSet Glenoid and humeral stem technologies. These systems are complemented by ProVoyance, an FDA-cleared preoperative planning technology that integrates artificial intelligence and machine learning to transform CT imaging into three-dimensional patient-specific renderings. The company also offers an efficient two-tray instrument system designed to streamline surgical workflows and reduce operating room complexity compared to traditional six to nine-tray systems.

Shoulder Innovations operates through a specialized commercial organization comprising dedicated shoulder specialists, a Customer Experience and Medical Education team, and a network of independent distributors. As of December 31, 2025, the company employed 45 shoulder specialists with over 750 years of combined direct selling and clinical education experience. The company's commercial strategy targets approximately 1,800 high-volume shoulder surgeons in the United States who perform the majority of procedures.

The company estimates the United States shoulder arthroplasty market at approximately 250,000 procedures annually, representing a $1.7 billion market opportunity, with expected growth of approximately 11 percent annually through 2029. The international shoulder arthroplasty market is estimated at approximately $1.0 billion annually, bringing the total addressable global market to approximately $2.7 billion. Since its initial commercial launch in 2016, the company's implants have been utilized in more than 17,500 procedures.

The company's ecosystem is supported by substantial clinical evidence, including published studies demonstrating improved patient outcomes, implant durability, and reduced revision rates. Shoulder Innovations maintains a robust pipeline of technologies in development, including fracture-specific systems, revision solutions, metal-sensitive implants, and a robotics platform designed to enhance surgical precision and workflow efficiency. The company's website is www.shoulderinnovations.com.

Company details
Sector
Healthcare
Industry
Surgical & Medical Instruments
Headquarters
GRAND RAPIDS, MI
Fiscal year end
December
CIK
1699350
SIC
3841

Financial performance, year by year

Fiscal 2025–2025 · USD
$-50.40M$-20.28M$9.85M$39.97M$70.10M2025Last 12 moLast 12 monthsLast 12 months

The full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.

Ownership

Who owns SHOULDER INNOVATIONS, INC. — and what changed

Funds as of 2026Q2 · superinvestors as of 2026-06-30

91
funds hold it
0 of 35
superinvestors hold it
$77.42M
held by funds, at market
24.1%
of shares held by funds

Largest fund holders · SHOULDER INNOVATIONS, INC.’s weight in each

Select Medical Technology and Devices Portfolio
FSMEX · Fidelity Select Portfolios
0.47%of fund net assets
Fidelity Small Cap Growth Fund
FCPGX · Fidelity Securities Fund
0.12%of fund net assets
Select Health Care Portfolio
FSPHX · Fidelity Select Portfolios
0.14%of fund net assets
Fidelity Balanced Fund
FBALX · Fidelity Puritan Trust
0.01%of fund net assets
VANGUARD TOTAL STOCK MARKET INDEX FUND
VTI · VANGUARD INDEX FUNDS
0.00%of fund net assets

Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.

Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.

Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.

Connected research

Put this business in context.

Compare this company with peers, find it in your funds and follow its financial history with your connected AI:

  • “How do SHOULDER INNOVATIONS, INC. and its peers compare on margins and cash generation over ten years?”
  • “Where did five years of SHOULDER INNOVATIONS, INC.'s earnings go — cash, debt, buybacks, reinvestment?”
  • “What changed in SHOULDER INNOVATIONS, INC.'s last four quarterly filings that the numbers alone won't show?”
See how it works →All research tools with a subscription. Use your own AI account.